ROCKVILLE, Md., July 28, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that it has appointed Patrick P. Vanek, R.Ph. to the newly-created position of Vice President of Operations.
